When is a PET/CT warranted for breast cancer?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Gfunk6

And to think . . . I hesitated
Moderator Emeritus
Lifetime Donor
20+ Year Member
Joined
Apr 16, 2004
Messages
4,660
Reaction score
5,075
I'm curious what practice patterns are out there. As a general rule, we obtain PET/CTs on all breast cancer patients with clinically node positive disease up front.

What are your indications for such?

Members don't see this ad.
 
We don't. We perform CT of the thorax and abdomen + bone scan for cN+ / pN+ patients, but PET is not being used in a regular basis for breast cancer.

Are there any data showing a clear advantage of PET vs. CT (with strategy changing implications)? I am aware of data in lung & esophagus, but I am not familiar with any in breast cancer.
 
We don't. We perform CT of the thorax and abdomen + bone scan for cN+ / pN+ patients, but PET is not being used in a regular basis for breast cancer.

Are there any data showing a clear advantage of PET vs. CT (with strategy changing implications)? I am aware of data in lung & esophagus, but I am not familiar with any in breast cancer.
There are some links provided in the NCCN guidelines to back up at least a Category 2B recommendation. The main take home point is that, like in Lung CA, PET/CT may better be able to assess and separate out the true Stage IV patients from others.

Here are a couple links:

http://www.ncbi.nlm.nih.gov/pubmed/20719497
http://www.ncbi.nlm.nih.gov/pubmed/15051773
 
Top